Kan Chen

Kan Chen

No open positions remaining
44 year
Health Technology
Consumer Services

Profile

Kan Chen is currently a Non-Executive Director at LongBio Pharma (Suzhou) Co., Ltd. and Ming Yu Pharmaceutical Ltd., both starting in 2025.
Former positions include Director at Jiangsu Yahong Meditech Co., Ltd. from 2020 to 2023; Non-Executive Director at Antengene Corp.
Ltd. from 2021 to 2024; Non-Executive Director at Abbisko Cayman Ltd. from 2020 to 2021; Non-Executive Director at CANbridge Pharmaceuticals Inc. from 2020 to 2024; Non-Executive Director at Connect Biopharma Holdings Ltd. from 2020 to 2025; and Non-Executive Director at InSilico Medicine Cayman TopCo from 2023 to 2026.
Education includes a doctorate from Harvard Medical School conferred in 2012, a doctorate from Case Western Reserve University conferred in 2009, and an undergraduate degree from Fudan University conferred in 2004.

Kan Chen active positions

CompaniesPositionStart

Former positions of Kan Chen

CompaniesPositionEnd
INSILICO MEDICINE CAYMAN TOPCO Director/Board Member 15/07/2026
CONNECT BIOPHARMA HOLDINGS LIMITED Director/Board Member 01/12/2025
CANBRIDGE PHARMACEUTICALS INC. Director/Board Member 01/09/2024
ANTENGENE CORPORATION LIMITED Director/Board Member 01/06/2024
JIANGSU YAHONG MEDITECH CO., LTD. Director/Board Member 01/12/2023
See the detail of Kan Chen's experience

Training of Kan Chen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology